0001209191-19-034054.txt : 20190603
0001209191-19-034054.hdr.sgml : 20190603
20190603181747
ACCESSION NUMBER: 0001209191-19-034054
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190530
FILED AS OF DATE: 20190603
DATE AS OF CHANGE: 20190603
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Parker Geoffrey M.
CENTRAL INDEX KEY: 0001491874
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35420
FILM NUMBER: 19874707
MAIL ADDRESS:
STREET 1: 15 RIORDAN PLACE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ChemoCentryx, Inc.
CENTRAL INDEX KEY: 0001340652
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943254365
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 850 MAUDE AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
BUSINESS PHONE: 650-210-2900
MAIL ADDRESS:
STREET 1: 850 MAUDE AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-05-30
0
0001340652
ChemoCentryx, Inc.
CCXI
0001491874
Parker Geoffrey M.
C/O CHEMOCENTRYX, INC.
850 MAUDE AVENUE
MOUNTAIN VIEW
CA
94043
1
0
0
0
Common Stock
2019-05-30
4
M
0
18010
6.00
A
85014
D
Common Stock
2019-05-30
4
S
0
12815
12.002
D
72199
D
Common Stock
99600
I
Geoffrey M Parker & Jill Gofen Parker Trustees of Geoffrey M Parker & Jill G Parker Revocable Trust
Common Stock
5000
I
By Delaware Charter Guarantee & Trust Company, Trustee FBO Mr. Geoffrey Monroe Parker IRA
Stock Option (right to buy)
6.00
2019-05-30
4
M
0
18010
D
2009-12-11
2019-12-11
Common Stock
18010
31990
D
Shares sold are associated with stock options that will expire in December 2019.
Reflects the weighted average sale price of the sales sold. The shares were sold in multiple trades at prices ranging from $11.85 to $12.115 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
As of May 30, 2019, and prior to this transaction, the exercised options were fully vested.
Not applicable.
/s/ Susan M. Kanaya, as Attorney-in-Fact
2019-06-03